Antipsychotic prescribing quality and ethnicity - A study of hospitalized patients in south east London (Journal of Psychopharmacology 21, 2, DOI: 10.1177/0269881107065899);Antipsychotic prescribing quality and ethnicity - A study of hospitalized patients in south east London

Journal of Psychopharmacology

Volumn 21, Issue 2, 2007, Pages 191-197

  Connolly, Anne ^a   Rogers, Paul ^b   Taylor, David ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

Antipsychotics; Polypharmacy; Prescribing; Race

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIPOTIAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; DRUG COST; DRUG MEGADOSE; DRUG QUALITY; ENGLISH AS A SECOND LANGUAGE; ETHNICITY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERVIEW; LICENSING; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; RISK; UNITED KINGDOM;

EID: 33847090821     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108096192     Document Type: Erratum

References (25)

1. American Psychiatric Association (2004) Practice Guideline for the Treatment of Patients With Schizophrenia, second edition. American Journal of Psychiatry 161 (suppl. 2). 1 - 56.
2. Baillargeon J, Contreras S A (2001) Antipsychotic prescribing patterns in the Texas prison system. Journal of the American Academy of Psychiatry and the Law 29: 48 - 53.
3. Ball J K, Elixhauser A (1996) Treatment differences between blacks and whites with colorectal cancer. Medical Care 34, 970 - 984.
4. Bazire S (2005) Psychotropic Drug Directory: The Professionals' Pocket Handbook and Aide Memoire. Fivepin Limited, Salisbury, UK
5. Claiborne-Johnson S, Fung L H, Gillum L A, Smith W S, Brass L M, Lichtman J H, Brown A N (2001) Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centres. The influence of ethnicity. Stroke 32: 1061 - 1068.
6. Copeland L A, Zeber J E, Valenstein M, Blow F C (2003) Racial disparity in the use of atypical antipsychotic medications among veterans. American Journal of Psychiatry 160: 1817 - 1822.
7. Corbie-Smith G, Thomas S B, Williams M V, Moody-Ayers S (1999) Attitudes and beliefs of African-Americans toward participation in medical research. Journal of General Internal Medicine 14: 537 - 546.
8. Covell N H, Jackson C T, Evans A C, Essock S M (2002) Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles. Schizophrenia Bulletin 28: 17 - 29.
9. Daumit G L, Crum R M, Guallar E, Powe N R, Primm A B, Steinwachs D M, Ford D E (2003) Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics and Whites in the United States. Archives of General Psychiatry 60: 121 - 128.
10. Diaz F J, de Leon J (2002) Excessive antipsychotic dosing in two US state hospitals. Journal of Clinical Psychiatry 63: 998 - 1003.
11. Flaskerud J H, Hu L (1992) Race/ethnic identity and amount and type of psychiatric treatment. American Journal of Psychiatry 149: 379 - 384.
12. Fleck D E, Hendricks W L, Del Bello M P, Strakowski S M (2002) Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder. Journal of Clinical Psychiatry 63: 658 - 664.
13. Kressin N R, Petersen L A (2001) Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Annals of Internal Medicine 135: 352 - 366.
14. Kreyenbuhl J, Zito J M, Buchanan R W, Soeken K L, Lehman A F (2003) Racial disparity in the pharmacological management of schizophrenia. Schizophrenia Bulletin 29, 183 - 193.
15. Kuno E., Rothbard A B (2002) Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. American Journal of Psychiatry 159: 567 - 572.
16. Opolka J L, Rascati K L, Brown C M, Barner J C, Johnsrud M T, Gibson P J (2003) Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. Journal of Clinical Psychiatry 64: 635 - 639.
17. Owen R R, Feng W, Thrush C R, Hudson T J, Austen M A (2001) Variations in prescribing practices for novel antipsychotic medications among veterans affairs hospitals. Psychiatric Services 52: 1523 - 1525.
18. Pinninti N R, Shaila B, Kumar G (2003) Racial bias in the prescription of atypical antipsychotics. Psychiatric Services 54: 110-110.
19. Segal S P, Bola J R, Watson M A (1996) Race, quality of care and antipsychotic prescribing practices in psychiatric emergency services. Psychiatric Services 47: 282 - 286.
20. Shavers-Hornaday V L, Lynch C F, Burmeister L F, Torner J C (1997) Why are African-Americans under-represented in medical research studies? Impediments to participation. Ethnicity and Health 2: 31 - 45.
21. Taylor D M (2004) Prescribing of clozapine and olanzapine: dosage, polypharmacy and patient ethnicity. Psychiatric Bulletin 28: 241 - 243.
22. Walkup J T, McAlpine D D, Olfson M, Labay L E, Boyer C, Hansell S (2000) Patients with schizophrenia at risk of excessive antipsychotic dosing. Journal of Clinical Psychiatry 61: 344 - 348.
23. Woods S W (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64: 663 - 667.
24. Woods S W, Sullivan M C, Neuse E C, Diaz E, Baker C B, Madonick S H, Griffith E E, Steiner (2003) Racial and ethnic effects on antipsychotic prescribing practices in a community mental health center. Psychiatric Services 54: 177 - 179.
25. Yorston G, Pinney A (2000) Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin 24: 130 - 132.